Alimera Sciences Names Elliot Maltz as Chief Financial Officer and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Stock Information for Coeptis Therapeutics Holdings Inc.
Loading
Please wait while we load your information from QuoteMedia.